UBA1 and cancer: In contrast to synthetically designed introns to target SF3B1 mutations60, we identified a natural cryptic alternative exon in the constitutively expressed ubiquitin-like modifier activating enzyme 1 (UBA1) that was observed exclusively in SF3B1 mutant cancers (Fig. 4g).